Printer Friendly

MEDCO CONTAINMENT SERVICES AND DIAGNOSTEK SETTLE LITIGATION

 NEW YORK, March 29 /PRNewswire/ -- Medco Containment Services, Inc. (NASDAQ-NMS: MCCS) and Diagnostek, Inc. (NYSE: DXK) today announced that they have reached an agreement to settle the litigation between them that is pending in Delaware Court of Chancery. Pursuant to the terms of the agreement, neither side admits any of the allegations in the action and Diagnostek has agreed to pay Medco a sum of $3 million.
 -0- 3/29/93
 /CONTACT: James V. Manning, senior executive vice president - finance of Medco Containment Services, Inc., 201-358-5830; or Vincent Villanueva, vice president - corporate & public affairs of Diagnostek, Inc., 505-345-8080; or Fred Spar of Kekst and Company, 212-593-2655, for Diagnostek/
 (MCCS DXK)


CO: Medco Containment Services, Inc.; Diagnostek, Inc. ST: New Jersey, New Mexico IN: MTC SU:

WB -- NY107 -- 0747 03/29/93 17:48 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 29, 1993
Words:134
Previous Article:CITADEL HOLDING CORP. COMPLETION OF RIGHTS OFFERING
Next Article:NOBLE AFFILIATES ANNOUNCES FULL REDEMPTION OF 7-1/4 PERCENT CONVERTIBLE DEBENTURES DUE 2012
Topics:


Related Articles
DIAGNOSTEK NAMED MAIL SERVICE PROVIDER FOR FIRST HEALTH STRATEGIES, INC.
NEW STUDY SHOWS PATIENTS VALUE MANAGED MENTAL HEALTH CARE MODEL
DIAGNOSTEK AND RIGHTCHOICE MANAGED CARE ANNOUNCE 5-YEAR AGREEMENT FOR PHARMACY BENEFIT MANAGEMENT SERVICES
VALUE HEALTH, INC. TO ACQUIRE DIAGNOSTEK, INC. To Create Largest Independent Prescription Drug Benefit Manager
VALUE HEALTH MOVES FORWARD WITH DIAGNOSTEK ACQUISITION
VALUE HEALTH, INC. CLOSES DEAL TO ACQUIRE DIAGNOSTEK, INC.
Medco Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Accredo Health Acquisition.
Shareholder Vote Scheduled for Approving Medco Acquisition of Accredo.
Medco Completes $2.3 Billion Acquisition of Accredo, Creates Largest Specialty/Biotech Pharmacy Operation.
Coventry Health Care Awards Medicare Pharmacy Services Contract to Medco.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters